Global Device Approvals Snapshot: April 9-15, 2019

15 Apr 2019

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, FDA approved Qiagen's therascreen FGFR RGQ RT-PCR companion diagnostic for Janssen's new drug to treat specific types of urothelial cancer and Intact Vascular's Tack device to treat dissections of the above-the-knee peripheral arteries following angioplasty.

[Editor's note: Complete historical data on global device approvals can be found in Medtech Insight's Approvals Tracker and at MedDeviceTracker].

The US FDA approved two original PMAs between April 9 and April 15.